Nasolacrimal Duct Obstruction

  • Andreas Marcotty


Successful management of the infant with chronic tearing and mucus discharge requires an understanding of the differential diagnosis and natural history of nasolacrimal duct obstruction. Equally important is an understanding of the timing of possible spontaneous resolution as well as medical and surgical treatment modalities that can be employed should spontaneous resolution not occur.


Tearing Nasolacrimal duct obstruction Tear duct massage Dacryocystocele Probe and irrigate Tear duct stent Balloon catheter dilation 


  1. 1.
    Kapadia MK, Freitag SK, Woog JJ. Evaluation and management of congenital nasolacrimal duct obstruction. Otolaryngol Clin North Am. 2006;39(5):959–77, vii.PubMedCrossRefGoogle Scholar
  2. 2.
    MacEwen CJ, Young JDH. The fluorescein disappearance test: an evaluation of its use in infants. J Pediatr Ophthalmol Strabismus. 1991;28:302–5.PubMedGoogle Scholar
  3. 3.
    Burkat CN, Lucarelli MJ. Tear meniscus level as an indicator of nasolacrimal obstruction. Ophthalmology. 2005;112(2):344–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Piotrowski JT, Diehl NN, Mohney BG. Neonatal dacryostenosis as a risk factor for anisometropia. Arch Ophthalmol. 2010;128(9):1166–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Mataftsi A, et al. High prevalence of amblyopia risk factors in preverbal children with nasolacrimal duct obstruction. J AAPOS. 2012;16(2):213–4; author reply 214.PubMedCrossRefGoogle Scholar
  6. 6.
    Matta NS, Singman EL, Silbert DI. Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction. J AAPOS. 2010;14(5):386–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Kendig EL, Guerry III D. The incidence of congenital impotency of the nasolacrimal duct. J Pediatr. 1950;36(2):212–3.PubMedCrossRefGoogle Scholar
  8. 8.
    MacEwen CJ, Young JDH. Epiphora during the first year of life. Eye (Lond). 1991;5:596–600.CrossRefGoogle Scholar
  9. 9.
    Kushner BJ. Congenital nasolacrimal system obstruction. Arch Ophthalmol. 1982;100(4):597–600.PubMedCrossRefGoogle Scholar
  10. 10.
    Weiss AH, Baran F, Kelly J. Congenital nasolacrimal duct obstruction: delineation of anatomic abnormalities with 3-dimensional reconstruction. Arch Ophthalmol. 2012;130(7):842–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Price HW. Dacryostenosis. J Pediatr. 1946;30:302–5.CrossRefGoogle Scholar
  12. 12.
    Moscato EE, Kelly JP, Weiss A. Developmental anatomy of the nasolacrimal duct: implications for congenital obstruction. Ophthalmology. 2010;117(12):2430–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Lee KA, et al. A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction. Am J Ophthalmol. 2013;156(5):1045–50.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Pediatric Eye Disease Investigator Group. Resolution of congenital nasolacrimal duct obstruction with nonsurgical management. Arch Ophthalmol. 2012;130(6):730–4.PubMedCentralCrossRefGoogle Scholar
  15. 15.
    Crigler LW. The treatment of congenital dacryocystitis. JAMA. 1923;81(1):23–4.CrossRefGoogle Scholar
  16. 16.
    Qian Y, Traboulsi EI. Lacrimal sac compression, not massage. J Pediatr Ophthalmol Strabismus. 2009;46(4):252.PubMedGoogle Scholar
  17. 17.
    Ali MJ, et al. Incomplete punctal canalisation: the external and internal punctal membranes. Outcomes of membranotomy and adjunctive procedures. Br J Ophthalmol. 2013;97(1):92–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Yuen SJ, Oley C, Sullivan TJ. Lacrimal outflow dysgenesis. Ophthalmology. 2004;111(9):1782–90.PubMedCrossRefGoogle Scholar
  19. 19.
    Sepulveda W, et al. Congenital dacryocystocele. Prenatal 2- and 3-dimensional sonographic findings. J Ultrasound Med. 2005;24:225–30.PubMedGoogle Scholar
  20. 20.
    Becker BB. The treatment of congenital dacryocystocele. Am J Ophthalmol. 2006;142(5):835–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Baskin DE, et al. The timing of antibiotic administration in the management of infant dacryocystitis. J AAPOS. 2008;12(5):456–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Kassoff J, Meyer DE. Early office-based vs. late hospital-based nasolacrimal duct probing. Arch Ophthalmol. 1995;113(9):1168–71.PubMedCrossRefGoogle Scholar
  23. 23.
    Kushner BJ. Early office-based vs. late hospital-based nasolacrimal duct probing. Arch Ophthalmol. 1995;113(9):1103–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Frick KD, Hariharan L, Repka MX, Chandler D, Melia BM, Beck RW, Pediatric Eye Disease Investigator Group. Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants. Arch Ophthalmol. 2011;129(5):603–9.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Pediatric Eye Disease Investigator Group, et al. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology. 2008;115(3):577–84.e3.CrossRefGoogle Scholar
  26. 26.
    Kushner BJ. The management of nasolacrimal duct obstruction in children between 18 months and 4 years old. J AAPOS. 1998;2(1):57–60.PubMedCrossRefGoogle Scholar
  27. 27.
    Kashkouli MB, Kassaee A, Tabatabaee Z. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success. J AAPOS. 2002;6(6):360–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Katowitz JA, Welsh MG. Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology. 1987;94(6):698–705.PubMedCrossRefGoogle Scholar
  29. 29.
    Young JDH, MacEwen CJ, Ogston SA. Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management. Eye (Lond). 1996;10:485–91.CrossRefGoogle Scholar
  30. 30.
    Al-Faky YH, et al. A prospective, randomised comparison of probing versus bicanalicular silastic intubation for congenital nasolacrimal duct obstruction. Br J Ophthalmol. 2015;99(2):246–50.CrossRefGoogle Scholar
  31. 31.
    Goldstein SM, Goldstein JB, Katowitz JA. Comparison of monocanalicular stenting and balloon dacryoplasty in secondary treatment of congenital nasolacrimal duct obstruction after failed primary probing. Ophthal Plast Reconstr Surg. 2004;20(5):352–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Kaufman LM, Guay-Bharia LA. Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction. Ophthalmology. 1998;105(2):336–41.PubMedCrossRefGoogle Scholar
  33. 33.
    Pediatric Eye Disease Investigator Group, et al. Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing. Arch Ophthalmol. 2009;127(5):633–9.PubMedCentralCrossRefGoogle Scholar
  34. 34.
    Pediatric Eye Disease Investigator Group, et al. Repeat probing for treatment of persistent nasolacrimal duct obstruction. J AAPOS. 2009;13(3):306–7.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Pediatric Eye Disease Investigator Group, et al. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. J AAPOS. 2008;12(5):445–50.PubMedCentralCrossRefGoogle Scholar
  36. 36.
    Prabhakaran VC, et al. Congenital absence of the nasolacrimal duct in velocardiofacial syndrome. J AAPOS. 2008;12(1):85–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Bartley GB. Lacrimal drainage anomalies in mandibulofacial dysostosis. Am J Ophthalmol. 1990;109(5):571–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Coats DK, et al. Nasolacrimal outflow drainage anomalies in Down’s syndrome. Ophthalmology. 2003;110(7):1437–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2016

Authors and Affiliations

  1. 1.Cleveland Clinic, Cole Eye Institute, BeachwoodBeachwoodUSA
  2. 2.Cleveland Clinic Lerner College of Medicine of Case Western Reserve UniversityClevelandUSA

Personalised recommendations